SOURCE: Quture International, Inc.

Quture International, Inc.

January 29, 2014 08:00 ET

Quture (OTCQB: QUTR) Prepares for Intended Growth and Engages Windmill for Communication Design and Management Services Including Social Media

DAYTONA BEACH, FL--(Marketwired - Jan 29, 2014) - Quture International, Inc. (OTCQB: QUTR) ("Q"), the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare, now with global capability and intentions through its subsidiary Quture Euro, today announced that in preparation for intended growth ahead, the Company has engaged Windmill (, a comprehensive provider of communication design and management services to small companies, for its suite of services including social media. Q's communications strategies are designed to increase investor awareness and, simultaneously, market its clinical intelligence products and services to the total array of potential health and healthcare customers.

Alongside management, Windmill's integrated team of specialists will assist Q in the optimization of its corporate branding, messaging and communication with the public and the investment community to better prepare for planned growth strategies. Q's first-to-market clinical performance management software QualOptima Connectivity & Analytics System, is the complete solution for providers, payers, employers and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. QualOptima electronically collects, measures and analyzes clinical data to determine the specific and aggregate clinical performance and outcomes of healthcare providers, medical devices, pharmaceuticals and more - empowering value-based, patient-centered and personalized care within the healthcare eco-system. Q's subsidiary QualVal Solutions can be contracted for the QualOptima software solution bundled with consulting services to assist in the transformation to value-driven care, new care delivery models (such as Accountable Care Organizations "ACO's") and to meet new regulatory requirements and accreditation standards.

"We believe 2014 will be a monumental year for Q," said Landon Feazell, Chairman & CEO of Quture International. "The Company is in the midst of transitioning from product development to revenue. Q's clinical trial results at University of Miami/Jackson Memorial Hospital will be published after patents are filed with marketing and sales demonstrations to immediately follow to supplement sales already in the pipeline. The perverse fee-for-service payment system currently in place in healthcare is shifting to fee-for-value and, therefore, to value-driven care. Q's innovations are positioned at that intersection and as such, we expect intended rapid growth to begin with the industry adoption of our first of its kind value-based, clinical intelligence software."

With a team experienced in corporate communications, social media, investor relations, financial marketing and consulting, psychology and design, Windmill is highly effective at servicing the modern communication needs of companies across a spectrum of industries. Utilizing modern branding, messaging and communication techniques, Windmill's mission is to comprehensively and affordably aid small companies to create, improve and build perception amongst social and investor communities. Communication design and management services include social media, press releases, marketing materials, public and investor contact, website implementation and more.

Regarding selection of Windmill, Mr. Feazell continued: "In preparation for what's to come, we have engaged Windmill, an experienced and versatile communications firm, to advise and aid us in conveying our opportunity and potential within the healthcare industry, to the public and the investment community via an array of modern channels including social media. In addition, they will be the representative communications arm for public and all inquiries moving forward. Their background and expertise with public companies should prove advantageous to us now and in the time ahead, particularly as we scale. Windmill will coordinate with Mele Telitz, Q's Director of Communications, for the Company's integrated marketing and investor awareness strategies. Mark Kroeger of Infinity Advisors will continue to assist the Company but in his more traditional role."

About Quture International, Inc.

Quture International (OTCQB: QUTR)("Q") is the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare. Q's first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. Q's QualOptima Connectivity & Analytics System empowers value-driven, patient-centered, personalized care focused on real-time and predictive patient management and patient safety, with optimal quality demonstrated by outcomes correlated with resource use, revenue and cost. As an Application Partner of InterSystems Corporation, Q's software operates on their HealthShare strategic technology platform to capture, integrate, aggregate, and analyze data transformed to knowledge in Q's innovative second-generation database. InterSystems ( has customers in over 100 countries with 80% of top hospitals in America currently utilizing its technology. Q's core competence and value proposition lies in its embedded evidence-based metrics, clinical content and analytic algorithms developed from over 35 years of measuring performance in hundreds of hospitals, physician organizations and HMO's. 

As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions. Q is a Nevada corporation based in Daytona Beach, Florida, and trades on the OTC exchange under the symbol 'QUTR.'

Forward Looking Statements: This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.

Contact Information